Shares of e-therapeutics plc (LON:ETX – Get Free Report) passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 11.85 ($0.15) and traded as low as GBX 8.54 ($0.11). e-therapeutics shares last traded at GBX 9.60 ($0.12), with a volume of 2,228,014 shares traded.
e-therapeutics Trading Down 2.1 %
The firm has a market cap of £54.92 million, a P/E ratio of -480.00 and a beta of 0.48. The company has a quick ratio of 20.13, a current ratio of 22.20 and a debt-to-equity ratio of 0.33. The firm’s 50-day simple moving average is GBX 12.36 and its 200 day simple moving average is GBX 11.85.
About e-therapeutics
e-therapeutics plc engages in drug discovery research activities in the United Kingdom. It offers HepNet, a proprietary, hepatocyte-specific, and computational biology platform that addresses key limitations of the biopharmaceutical industry, including extracting value from big data, addressing complex diseases, and improving translatability in research and development; and GalOmic, a RNA interference (RNAi) chemistry platform, which enables the generation of GalNAc-conjugated short interfering RNA drug candidates for hepatocyte-specific gene silencing through RNAi of any target gene identified by HepNet.
Further Reading
- Five stocks we like better than e-therapeutics
- Utilities Stocks Explained – How and Why to Invest in Utilities
- Hasbro’s Management Made All the Right Calls This Quarter
- How to Use the MarketBeat Excel Dividend Calculator
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- How to Calculate Stock Profit
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for e-therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for e-therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.